About Vixen Bio

Vixen Bio is a functional immunology company supporting biotech and pharma R&D teams with complex therapy-development questions. We combine scientific expertise, custom assay development and laboratory execution to generate functional immune-response evidence in clinically relevant samples and conditions.

Our work sits where molecular interaction, immune function and human context meet. Depending on the project, we combine real-time interaction analysis, functional immune-cell assays, biomarker strategies and mechanistic interpretation to support candidate selection, mechanism-of-action understanding and translational decisions.

We are tool-aware, not tool-limited. Rather than forcing every project onto one platform, we select and adapt the most appropriate approach for the scientific objective and the evidence required.

Vixen aims to work as an integrated scientific partner rather than a protocol-execution provider. We start from the development challenge, build the appropriate evidence package around it and help customers interpret what should move forward, what needs further investigation and what may need to change.

Our team brings together expertise in immunology, biosensing, assay development, diagnostics, protein biology and life-science commercialisation, allowing us to connect detailed laboratory measurements with the wider development decisions they need to inform.